On ECHEMI
Home > Drugs > Beijing Saier Biological Pharmaceutical Co., Ltd.
Beijing Saier Biological Pharmaceutical Co., Ltd.
  • Founded in:

    2002-10-24
  • Country:

    China China
  • Address:

    No. 35, Keyuan Road, Industrial Development Zone, Daxing District, Beijing
  • Tax NO.:

    91110115742602836G
  • Registered Funds:

    28 million yuan
  • Website:

  • Email:

Related Drugs
Domperidone Capsules
Domperidone.
Name Description Content CAS NO. Registered Holders
Domperidone

This product is a peripheral dopamine receptor antagonist, which can promote the peristalsis and tension of the upper gastrointestinal tract to return to normal, promote gastric emptying, increase the movement of the gastric antrum and duodenum, coordinate the contraction of the pylorus, and also enhance the peristalsis of the esophagus and the tension of the lower esophageal sphincter, inhibit nausea and vomiting, and do not affect the secretion of gastric juice. This product is not easy to pass through the blood-brain barrier and has almost no antagonistic effect on dopamine receptors in the brain, so it generally has no adverse reactions to the mental and central nervous systems.

More

This product is a peripheral dopamine receptor antagonist, which can promote the peristalsis and tension of the upper gastrointestinal tract to return to normal, promote gastric emptying, increase the movement of the gastric antrum and duodenum, coordinate the contraction of the pylorus, and also enhance the peristalsis of the esophagus and the tension of the lower esophageal sphincter, inhibit nausea and vomiting, and do not affect the secretion of gastric juice. This product is not easy to pass through the blood-brain barrier and has almost no antagonistic effect on dopamine receptors in the brain, so it generally has no adverse reactions to the mental and central nervous systems.

57808-66-9 19
Domperidone Capsules
Domperidone.
Name Description Content CAS NO. Registered Holders
Domperidone

This product is a peripheral dopamine receptor antagonist, which can promote the peristalsis and tension of the upper gastrointestinal tract to return to normal, promote gastric emptying, increase the movement of the gastric antrum and duodenum, coordinate the contraction of the pylorus, and also enhance the peristalsis of the esophagus and the tension of the lower esophageal sphincter, inhibit nausea and vomiting, and do not affect the secretion of gastric juice. This product is not easy to pass through the blood-brain barrier and has almost no antagonistic effect on dopamine receptors in the brain. Therefore, it generally has no adverse reactions to the mental and central nervous systems.

More

This product is a peripheral dopamine receptor antagonist, which can promote the peristalsis and tension of the upper gastrointestinal tract to return to normal, promote gastric emptying, increase the movement of the gastric antrum and duodenum, coordinate the contraction of the pylorus, and also enhance the peristalsis of the esophagus and the tension of the lower esophageal sphincter, inhibit nausea and vomiting, and do not affect the secretion of gastric juice. This product is not easy to pass through the blood-brain barrier and has almost no antagonistic effect on dopamine receptors in the brain. Therefore, it generally has no adverse reactions to the mental and central nervous systems.

57808-66-9 19
Domperidone Capsules
Domperidone.
Name Description Content CAS NO. Registered Holders
Domperidone

This product is a peripheral dopamine receptor antagonist, which can promote the peristalsis and tension of the upper gastrointestinal tract to return to normal, promote gastric emptying, increase the movement of the gastric antrum and duodenum, coordinate the contraction of the pylorus, and also enhance the peristalsis of the esophagus and the tension of the lower esophageal sphincter, inhibit nausea and vomiting, and do not affect the secretion of gastric juice. This product is not easy to pass through the blood-brain barrier and has almost no antagonistic effect on dopamine receptors in the brain. Therefore, it generally has no adverse reactions to the mental and central nervous systems.

More

This product is a peripheral dopamine receptor antagonist, which can promote the peristalsis and tension of the upper gastrointestinal tract to return to normal, promote gastric emptying, increase the movement of the gastric antrum and duodenum, coordinate the contraction of the pylorus, and also enhance the peristalsis of the esophagus and the tension of the lower esophageal sphincter, inhibit nausea and vomiting, and do not affect the secretion of gastric juice. This product is not easy to pass through the blood-brain barrier and has almost no antagonistic effect on dopamine receptors in the brain. Therefore, it generally has no adverse reactions to the mental and central nervous systems.

57808-66-9 19
Sophora flavescens tablets
The main ingredient of this product and its chemical name is oxymatrine.
Name Description Content CAS NO. Registered Holders
Ammothamnine

This product can reduce the level of DHBV-DNA in the serum of ducks infected with duck hepatitis B virus (DHBV); it has a protective effect on toxic liver damage in mice caused by CCl4 and D-galactosamine.

More

This product can reduce the level of DHBV-DNA in the serum of ducks infected with duck hepatitis B virus (DHBV); it has a protective effect on toxic liver damage in mice caused by CCl4 and D-galactosamine.

16837-52-8 11
Sodium valproate tablets
Valproic acid
Name Description Content CAS NO. Registered Holders
2-Propylpentanoic acid

Increase the synthesis of GABA and reduce the degradation of GABA, thereby increasing the concentration of the inhibitory neurotransmitter g-aminobutyric acid (GABA), reducing the excitability of neurons and inhibiting seizures. In electrophysiological experiments, this product can produce an inhibitory effect on Na channels similar to that of phenytoin. It is harmful to the liver.

More

Increase the synthesis of GABA and reduce the degradation of GABA, thereby increasing the concentration of the inhibitory neurotransmitter g-aminobutyric acid (GABA), reducing the excitability of neurons and inhibiting seizures. In electrophysiological experiments, this product can produce an inhibitory effect on Na channels similar to that of phenytoin. It is harmful to the liver.

99-66-1 29
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.